FISH-Based Test to Diagnose Melanoma is Goal of Neogenomics

Deal with Abbott Labs gives Neogenomics access to proprietary probes Diagnostic testing for melanoma generates a substantial number of tests annually, making it a lucrative target for any clinical laboratory or biotech company that can develop an assay that utilizes state-of-the-art molecular technologies and offers improved detection and accuracy. Once company working to develop such a new diagnostic test for melanoma is Neogenomics, Inc. (OTC:NGNM.OB).  It announced an agreement with Abbott...

Three Trends Now Fueling Wider Adoption of Digital Pathology

Upcoming Pathology Visions conference will tackle digital pathology advances Digital pathology is entering a new phase of adoption marked by three significant trends. This is the assessment of Dirk Soenksen, Founder and CEO of Aperio Technologies, Inc., in Vista, California. He believes these three trends are working together to accelerate the adoption of digital imaging and digital pathology systems by pathology laboratories across the nation. Soenksen has observed the following three trends...

Boston’s Caritas Christi Health Sells its Lab Outreach Business, Forms Alliance with Quest Diagnostics

It’s the second acquisition of a hospital lab outreach program in past six days Several days ago, a two-part deal was announced between Quest Diagnostics Incorporated (NYSE:DGX) and Caritas Christi Health Care of Boston, Massachusetts. Caritas sold its clinical laboratory outreach business to Quest Diagnostics and both parties formed a “strategic alliance” going forward that centers upon laboratory testing and informatics integration. Caritas will continue to own and manage the laboratories in...

Sonic Healthcare’s Latest Lab Buying Spree Nets Two U.S. Labs for $20 Million

Sonic purchased Piedmont Medical Laboratory of Winchester, Virginia, and Axiom Laboratories, of Tampa, Florida Yesterday, Sonic Healthcare, Ltd., of Sydney, Australia, officially recognized the acquisition of two clinical laboratories in the United States: Piedmont Medical Laboratory of Winchester, Virginia, and Axiom Laboratories, of Tampa. The Axiom transaction was closed earlier this summer. For both labs, Sonic will pay $20 million in cash and could pay $2.5 million more in...

Consolidation of Nation’s Health Insurers Is Bad Medicine for Local Labs and Pathologists

While no one was looking, nine big insurers grabbed 76.7% of privately-insured patients! Consolidation of major health insurance companies in recent years is a trend which reinforced the market clout of the nation’s two largest lab companies at the expense of local laboratories and pathology groups. However, few pathologists and clinical lab managers know precisely how much market power is currently concentrated into the hands of only a few health insurance companies. Dark Daily now unveils a...
;